Newsmeme!
Discover News you didn't know existed
FRIDAY, Aug. 8 (HealthDay News) -- In what they say may be the first operation of its kind in the United States, surgeons at New York-Presbyterian Hospital/Columbia University Medical Center removed a woman's gallbladder without making any external incisions.
All ISS systems continue to function nominally, except those noted previously or below.
Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of three ongoing phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx® BUPIVACAINE SURGICAL IMPLANT for the management of post-operative pain.
Scientists at the University of Liverpool have identified an enzyme that could be responsible for a condition called endometriosis -- the most common cause of pelvic pain in women Endometriosis is a condition whereby patches of the inner lining of the womb appear in parts of the body other than the womb cavity. It can cause severe pain and affects approximately 15% of women of reproductive age.
Scientists at the University of Liverpool have identified an enzyme that could be responsible for a condition called endometriosis - the most common cause of pelvic pain in women.
Endometriosis is a condition whereby patches of the inner lining of the womb appear in parts of the body other than the womb cavity. It can cause severe pain and affects approximately 15% of women of reproductive age. Endometriosis is also associated with infertility, with 50% of infertile women affected by the condition.
Endometriosis is a condition whereby patches of the inner lining of the womb appear in parts of the body other than the womb cavity. It can cause severe pain and affects approximately 15% of women of reproductive age.
Scientists have identified an enzyme that could be responsible for a condition called endometriosis – the most common cause of pelvic pain in women.
According to scientists in the U.S., a high dose of vitamin C given in the form of an injection may halt the spread of cancers.
Switching from other protease inhibitors to atazanavir/ritonavir does not significantly reduce visceral fat accumulation in the abdomen – a feature of the lipodystrophy syndrome - according to 48-week results of a randomised trial presented on Monday at the XVII International AIDS Conference in Mexico City.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |